Advances in and applications of proteasome inhibitors

This publication has 44 references indexed in Scilit:

• Engineered Biosynthesis of Antiprotealide and Other Unnatural Salinosporamide Proteasome Inhibitors
  Journal of the American Chemical Society, 2008
• Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis
  Chemistry & Biology, 2008
• Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade
  Clinical Cancer Research, 2008
• Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma
  Blood, 2008
• Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB–regulated gene products
  Blood, 2007
• NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
  Blood, 2007
• Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica
  Proceedings of the National Academy of Sciences, 2007
• A novel proteasome inhibitor NPI-0052 as an anticancer therapy
  British Journal of Cancer, 2006
• Crystal Structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in Complex with the 20S Proteasome Reveal Important Consequences of β-Lactone Ring Opening and a Mechanism for Irreversible Binding
  Journal of the American Chemical Society, 2006
• Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora
  Angewandte Chemie International Edition in English, 2003